
Ambio Life Sciences Launches World's First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions
Facilities and care team tailored for patients with complex medical needs Specialized protocol includes optimized dosing and therapeutic support for patients with conditions like Parkinson's and multiple sclerosis Initial cohort of patients includes …